Forum

Master post-approval CMC changes and pharmaceutical lifecycle management under ICH Q12. Learn how Established Conditions (ECs), PACMPs, and PLCM documents reduce regulatory burden, streamline EMA/FDA submissions, and drive continuous operational improvement across global supply chains.

Ensure seamless EU marketing authorization with Zenovel’s expert Environmental Risk Assessment (ERA) services. We guide pharmaceutical companies through the complete EMA framework—from Phase I exposure estimation and Phase II fate testing (Tier A/B) to PBT screening, literature justification, and multi-market PEC harmonization. Avoid submission delays and bridge your clinical and CMC data with our specialized regulatory support.